81 results
S-3ASR
IMNM
Immunome Inc
3 Apr 24
Automatic shelf registration
4:40pm
of novel or underexplored targets will be central to the next generation of transformative therapies. For that reason, we pursue therapeutics that we … and develop a broad pipeline of ADCs, as different targets may require different payloads to achieve optimal efficacy and therapeutic index. The novel
S-3ASR
IMNM
Immunome Inc
3 Apr 24
Automatic shelf registration
4:36pm
believe that the pursuit of novel or underexplored targets will be central to the next generation of transformative therapies. For that reason, we … and payloads is necessary to design and develop a broad pipeline of ADCs, as different targets may require different payloads to achieve optimal efficacy
8-K
EX-99.1
f9h70f3zlx3mm
28 Mar 24
Immunome Reports Full-Year 2023 Financial Results and Provides Update on Recently Acquired Assets
4:04pm
8-K
EX-99.1
wx4law7r4zwzmfo4
26 Mar 24
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
8:05am
8-K
EX-10.1
7d3msxcva 7myee8
26 Mar 24
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
8:05am
424B5
8t5p7cac
14 Feb 24
Prospectus supplement for primary offering
4:09pm
424B5
nwrw3y
13 Feb 24
Prospectus supplement for primary offering
4:36pm
8-K
EX-99.1
76o1fkpuimugiff
13 Feb 24
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.2
mz4vpa b5p
13 Feb 24
Results of Operations and Financial Condition
4:10pm
S-3ASR
mr3xw
13 Feb 24
Automatic shelf registration
4:04pm
8-K
EX-2.1
hd03qh fap61hxq
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
8-K
EX-99.1
o6sewejds6j i1l9l29
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
8-K
EX-99.1
3l5pj4c d2465
11 Jan 24
Regulation FD Disclosure
5:27pm
8-K
EX-99.1
3b1nb
8 Jan 24
Entry into a Material Definitive Agreement
7:05am
8-K
EX-99.1
xs07gg3et e0ph
15 Nov 23
Regulation FD Disclosure
6:03am